Article Information
History
- October 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- P-S. Smith1,x,
- T. Bradley1,x,
- L. Morrill Gavarró1,
- T. Goranova1,
- D. Ennis2,
- H. Mirza2,
- D. De Silva1,
- A.M. Piskorz1,
- S. Al-Khalidi1,
- C. Sauer1,
- I-G. Funingana1,
- M. Reinius1,
- G. Giannone2,
- L-A. Lewsley3,
- J. Stobo3,
- J. McQueen3,
- G. Bryson4,
- M. Eldridge1,
- The BriTROC Investigators5,
- G. Macintyre1,6,
- F. Markowetz1,†,
- J.D. Brenton1,†,* and
- I.A. McNeish2,†,*
- 1CRUK Cambridge Institute, University of Cambridge, UK
- 2Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, UK
- 3CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
- 4Department of Histopathology, Queen Elizabeth University Hospital, Glasgow, UK
- 6Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
- ↵*To whom correspondence should be addressed: Professor Iain McNeish, Imperial College London, IRDB Building, Hammersmith Hospital, W12 0NN, UK, i.mcneish{at}imperial.ac.uk, Professor James D. Brenton, CRUK Cambridge Institute, University of Cambridge, CB2 0RE, UK
↵x These authors contributed equally to this work